Authors: Queneau, PE Osaer, F Bronowicki, JP Monnot, B Thiefin, G Bettinger, D Carbillet, JP Raabe, JJ Fratte, S Minello-Franza, A Bresson-Hadni, S Miguet, JP

Citation: Pe. Queneau et al., Treatment of mild chronic hepatitis C with interferon alpha-2b: results ofa multi-centre randomized study in 80 patients, EUR J GASTR, 13(2), 2001, pp. 143-147

Authors: Boucher, E Guyader, D Jacquelinet, S Andre, P Mendler, MH Turlin, B Canva, V Nousbaum, JB Bernard, PH Nouel, O Raabe, JJ Dao, T Gasser, P Verger, P Boutin, J Bergerault, P Joram, F Colmar, P Messner, M Brissot, P Deugnier, Y

Citation: E. Boucher et al., Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patients, DIG LIVER D, 32(1), 2000, pp. 29-33

Authors: Poupon, RE Bonnand, AM Queneau, PE Trepo, C Zarski, JP Vetter, D Raabe, JJ Thieffin, G Larrey, D Grange, JD Capron, JP Serfaty, L Chretien, Y Girardin, MFS Mathiex-Fortunet, H Zafrani, ES Guechot, J Beuers, U Paumgartner, G Poupon, R

Citation: Re. Poupon et al., Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon, SC J GASTR, 35(6), 2000, pp. 642-649